# Study of KD026 in Combination With Metformin in Subjects With Type 2 Diabetes Mellitus

Study · id `cardio:ct-nct02434744` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02434744](<https://clinicaltrials.gov/study/NCT02434744>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02434744

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 121 participants.

## Technical summary

Registry record NCT02434744. Randomized; quadruple masking; primary purpose treatment. Start 2015-04 (registry gives no type); primary completion 2016-03 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 121 participants (enrolled count; ClinicalTrials.gov record NCT02434744, source copy `cardio:ctgov-nct02434744-2023-11-18`, retrieved 2026-10-26)
- Start date: 2015-04 (registry gives no type) (ClinicalTrials.gov record NCT02434744, source copy `cardio:ctgov-nct02434744-2023-11-18`, retrieved 2026-10-26)
- Primary completion: 2016-03 (actual) (ClinicalTrials.gov record NCT02434744, source copy `cardio:ctgov-nct02434744-2023-11-18`, retrieved 2026-10-26)
- Completion: 2016-03 (actual) (ClinicalTrials.gov record NCT02434744, source copy `cardio:ctgov-nct02434744-2023-11-18`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT02434744, source copy `cardio:ctgov-nct02434744-2023-11-18`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02434744-2023-11-18`, retrieved 2026-10-26)

## The registry's words

- Brief title: Study of KD026 in Combination With Metformin in Subjects With Type 2 Diabetes Mellitus
- Condition: Type 2 Diabetes Mellitus
- Intervention (Drug): KD026
- Intervention (Drug): Placebo
- Intervention (Drug): Metformin
- Lead sponsor: Response Pharmaceuticals
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)

## Provenance

Content hash: c8f4f9db587080715683e6c74a19e4c028290b85ff1c78646a38f7a9b84ad5f6
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
